Durect Share Price (NASDAQ: DRRX)

$1.92

Live

Last updated on August 26, 2025 at 12:42 AM IST

$₹

Check the interactive Durect Stock chart to analyse performance

Durect Corp Key Stats

Check Durect key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.92
Open	$1.92
Market Capitalization	$59.6M
Today's Volume	$417.0K
Revenue TTM	$1.7M
EBITDA	$-15.2M
Earnings Per Share (EPS)	$-0.43
Profit Margin	-209.9%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-307.39%

Stock Returns calculator for Durect Stock including INR - Dollar returns

The Durect stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Durect investment value today

Current value as on today

₹1,35,842

Returns

₹35,842

(+35.84%)

Returns from Durect Stock

₹31,507 (+31.51%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Durect Stock

2060.0%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Investment in Durect Shares from India has grown by 2060.0% over the past 30 days, indicating increased transactional activity.

282%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Durect Stock from India on INDmoney has increased by 282% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Durect Corp

Name
Holdings %
Name
Holdings %
Ingalls & Snyder LLC
4.35%
Richmond Brothers Inc
4.34%
Vanguard Group Inc
4.08%
Dalton Investments LLC.
2.40%
Gagnon Securities LLC
1.30%
Geode Capital Management, LLC
1.07%

Analyst Recommendation on Durect Stock

Rating

Trend

Buy

70%Buy

30%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Durect(by analysts ranked 0 to 5 stars)

Durect Share Price Target

What analysts predicted

Upside of 30.21%

Target:

$2.50

Current:

$1.92

Durect share price target is $2.50, a slight Upside of 30.21% compared to current price of $1.92 as per analysts' prediction.

Durect Stock Insights

Price Movement
In the last 1 month, DRRX stock has moved up by 238.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 321.0K → 447.0K (in $), with an average increase of 28.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.23M → -2.26M (in $), with an average increase of 86.8% per quarter
DRRX vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 55.4% return, outperforming this stock by 132.8%

Durect Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$29.6M	↑ 59.25%
Net Income	$-20.6M	↓ 18.73%
Net Profit Margin	-69.6%	↑ 66.8%

	FY20	Y/Y Change
Revenue	$30.1M	↑ 1.85%
Net Income	$-13.4M	↓ 34.75%
Net Profit Margin	-44.59%	↑ 25.01%

	FY21	Y/Y Change
Revenue	$14.0M	↓ 53.58%
Net Income	$-36.3M	↑ 170.09%
Net Profit Margin	-259.46%	↓ 214.87%

	FY22	Y/Y Change
Revenue	$19.3M	↑ 37.96%
Net Income	$-35.3M	↓ 2.57%
Net Profit Margin	-183.23%	↑ 76.23%

	FY23	Y/Y Change
Revenue	$8.5M	↓ 55.67%
Net Income	$-27.6M	↓ 21.82%
Net Profit Margin	-323.16%	↓ 139.93%

	FY24	Y/Y Change
Revenue	$2.0M	↓ 76.24%
Net Income	$-8.3M	↓ 69.87%
Net Profit Margin	-409.85%	↓ 86.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.8M	↓ 31.55%
Net Income	$-7.6M	↑ 430.4%
Net Profit Margin	-418.34%	↓ 364.35%

	Q2 FY24	Q/Q Change
Revenue	$2.2M	↑ 18.83%
Net Income	$-3.7M	↓ 51.59%
Net Profit Margin	-170.43%	↑ 247.91%

	Q3 FY24	Q/Q Change
Revenue	$1.9M	↓ 11.24%
Net Income	$-4.3M	↑ 15.81%
Net Profit Margin	-222.37%	↓ 51.94%

	Q4 FY24	Q/Q Change
Revenue	$453.0K	↓ 76.49%
Net Income	$7.3M	↓ 270.46%
Net Profit Margin	1.6K%	↑ 1834.73%

	Q1 FY25	Q/Q Change
Revenue	$321.0K	↓ 29.14%
Net Income	$-4.2M	↓ 157.94%
Net Profit Margin	-1.3K%	↓ 2930.74%

	Q2 FY25	Q/Q Change
Revenue	$447.0K	↑ 39.25%
Net Income	$-2.3M	↓ 46.48%
Net Profit Margin	-506.71%	↑ 811.67%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$25.4M	↑ 77.76%

	FY20	Y/Y Change
Profit	$28.7M	↑ 12.92%

	FY21	Y/Y Change
Profit	$12.0M	↓ 58.12%

	FY22	Y/Y Change
Profit	$17.7M	↑ 47.19%

	FY23	Y/Y Change
Profit	$6.8M	↓ 61.4%

	FY24	Y/Y Change
Profit	$2.0M	↓ 71.41%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.5M	↓ 23.52%

	Q2 FY24	Q/Q Change
Profit	$1.8M	↑ 18.01%

	Q3 FY24	Q/Q Change
Profit	$1.4M	↓ 22.09%

	Q4 FY24	Q/Q Change
Profit	$431.0K	↓ 69.52%

	Q1 FY25	Q/Q Change
Profit	$252.0K	↓ 41.53%

	Q2 FY25	Q/Q Change
Profit	$440.0K	↑ 74.6%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$11.1M	↓ 156.21%
Investing Cash Flow	$-27.3M	↓ 702.25%
Financing Cash Flow	$19.5M	↑ 11.56%

	FY20	Y/Y Change
Operating Cash Flow	$-38.7M	↓ 448.65%
Investing Cash Flow	$9.4M	↓ 134.52%
Financing Cash Flow	$15.7M	↓ 19.7%

	FY21	Y/Y Change
Operating Cash Flow	$-37.3M	↓ 3.6%
Investing Cash Flow	$15.3M	↑ 62.33%
Financing Cash Flow	$50.5M	↑ 222.68%

	FY22	Y/Y Change
Operating Cash Flow	$-26.3M	↓ 29.57%
Investing Cash Flow	$19.8M	↑ 29.55%
Financing Cash Flow	$83.0K	↓ 99.84%

	FY23	Y/Y Change
Operating Cash Flow	$-34.4M	↑ 30.95%
Investing Cash Flow	$-1.2M	↓ 105.88%
Financing Cash Flow	$20.5M	↑ 24595.18%

	FY24	Y/Y Change
Operating Cash Flow	$-19.1M	↓ 44.54%
Investing Cash Flow	$18.0M	↓ 1647.51%
Financing Cash Flow	$-16.3M	↓ 179.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.8M	↓ 18.73%
Investing Cash Flow	$-887.0K	↓ 14.22%
Financing Cash Flow	$-1.5M	↑ 21.94%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-3.7M	↓ 45.82%
Investing Cash Flow	$2.2M	↓ 348.03%
Financing Cash Flow	$-2.1M	↑ 43.14%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-3.1M	↓ 14.4%
Investing Cash Flow	$-1.3M	↓ 158.14%
Financing Cash Flow	$-2.1M	↑ 0.14%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-5.5M	↑ 75.78%
Investing Cash Flow	$18.0M	↓ 1508.13%
Financing Cash Flow	$-10.6M	↑ 393.19%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-3.5M	↓ 35.75%
Investing Cash Flow	$496.0K	↓ 97.25%
Financing Cash Flow	$0.0	↓ 100.0%

Durect Technicals Summary

Sell

Neutral

Buy

Durect is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Durect Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Durect Corp	247.39%	143.04%	31.51%	-77.86%	-90.35%
Haleon Plc Spon Ads	1.24%	-3.25%	-0.51%	57.62%	32.52%
United Therapeutics Corporation	4.73%	-12.84%	-9.93%	45.02%	75.59%
Zoetis Inc.	3.89%	-5.26%	-13.74%	-2.05%	-1.97%
Neurocrine Biosciences Inc.	1.29%	13.7%	-11.06%	29.14%	21.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Durect Corp	NA	NA	-0.46	-0.66	-3.07	-0.45	NA	0.11
Haleon Plc Spon Ads	21.82	21.82	3.16	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.18	12.18	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.96	26.96	2.54	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	39.95	39.95	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Durect Corp	Buy	$59.6M	-90.35%	NA	-209.9%
Haleon Plc Spon Ads	Buy	$44.2B	32.52%	21.82	13.81%
United Therapeutics Corporation	Buy	$14.1B	75.59%	12.18	40.36%
Zoetis Inc.	Buy	$69.4B	-1.97%	26.96	27.83%
Neurocrine Biosciences Inc.	Buy	$13.4B	21.15%	39.95	13.88%

About Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; PERSERIS, an injectable suspension for the treatment of schizophrenia in adults; and Methydur to treat attention deficit hyperactivity disorder. It has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Organization	Durect
Employees	13
CEO	Dr. James E. Brown D.V.M.
Industry	Health Technology

Key Management of Durect Corp

Name	Title
Dr. James E. Brown D.V.M.	Co-Founder, CEO, President & Director
Mr. Timothy M. Papp M.B.A.	CFO & Secretary
Dr. Norman L. Sussman M.D.	Chief Medical Officer
Ms. Judy R. Joice	Senior Vice President of Operations & Corporate Quality Assurance
Mr. Steve Helmer J.D.	VP & Chief Patent Counsel
Dr. WeiQi Lin M.D., Ph.D.	Executive VP of Research & Development and Principal Scientist
Ms. Jian Li M.B.A.	SVP of Finance & Corporate Controller
Dr. Su Il Yum Ph.D.	Executive Officer

Important FAQs about investing in DRRX Stock from India :

What is Durect share price today?

Durect share price today is $1.92 as on August 26, 2025 at 12:42 AM IST. Durect share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Durect share?

Durect share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Durect stock price today i.e. August 26, 2025 at 12:42 AM IST is trending at $1.92, lower by 27.27% versus the 52 week high.

How to invest in Durect Stock (DRRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Durect on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Durect Shares that will get you 0.7813 shares as per Durect share price of $1.92 per share as on August 26, 2025 at 12:42 AM IST.

What is the minimum amount required to buy Durect Stock (DRRX) from India?

Indian investors can start investing in Durect (DRRX) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Durect stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Durect share’s latest price of $1.92 as on August 26, 2025 at 12:42 AM IST, you will get 5.2083 shares of Durect. Learn more about fractional shares .

What are the returns that Durect has given to Indian investors in the last 5 years?

Durect stock has given -90.35% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?